Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 3/20 | 1.00 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.78 |
| ▸ | CETP | P11597 | 1/20 | 0.76 |
| ▸ | NT5E | P21589 | 9/20 | 0.73 |
| ▸ | PRKCG | P05129 | 2/20 | 0.69 |
| ▸ | GPBAR1 | Q8TDU6 | 2/20 | 0.66 |
| ▸ | USP2 | O75604 | 1/20 | 0.66 |
| ▸ | LMNA | P02545 | 1/20 | 0.66 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.66 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.66 |
| ▸ | ALB | P02768 | 1/20 | 0.66 |
| ▸ | POLB | P06746 | 1/20 | 0.66 |
| ▸ | GLI1 | P08151 | 1/20 | 0.66 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.66 |
| ▸ | DPP4 | P27487 | 1/20 | 0.66 |
| ▸ | RORC | P51449 | 1/20 | 0.66 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.66 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bevirimat SCHEMBL12565073 | 1.00 | PTPN1 (1.00) | PTPN1PRKCDCETPNT5EPRKCG | |
| Bevirimat SCHEMBL19480543 | 1.00 | PTPN1 (1.00) | PTPN1PRKCDCETPNT5EPRKCG | |
| Bevirimat SCHEMBL2612026 | 1.00 | PTPN1 (1.00) | PTPN1PRKCDCETPNT5EPRKCG | |
| Bevirimat SCHEMBL16272373 | 1.00 | PTPN1 (1.00) | PTPN1PRKCDCETPNT5EPRKCG | |
| Bevirimat SCHEMBL10061308 | 1.00 | PTPN1 (1.00) | PTPN1PRKCDCETPNT5EPRKCG | |
| SCHEMBL13222940 | 0.95 | PTPN1 (0.91) | PTPN1PRKCDCETPNT5EPRKCG | |
| SCHEMBL2620136 | 0.94 | PTPN1 (0.88) | PTPN1PRKCDCETPNT5EPRKCG | |
| SCHEMBL16330184 | 0.94 | PTPN1 (0.88) | PTPN1PRKCDCETPNT5EPRKCG | |
| SCHEMBL12915116 | 0.94 | PTPN1 (0.88) | PTPN1PRKCDCETPNT5EPRKCG | |
| SCHEMBL13075129 | 0.94 | PTPN1 (0.88) | PTPN1PRKCDCETPNT5EPRKCG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3411381-A1 | C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS | VIIV Healthcare UK (No.5) Limited (GB) | 2018-12-12 | — | — | EP | disclosed |
| EP-3218388-A1 | C17-ARYL SUBSTITUTED BETULINIC ACID ANALOGS | VIIV Healthcare UK (No.5) Limited (GB) | 2017-09-20 | — | — | EP | disclosed |
| EP-3218389-A1 | EXTENDED BETULINIC ACID ANALOGS | VIIV Healthcare UK (No.5) Limited (GB) | 2017-09-20 | — | — | EP | disclosed |
| EP-3218387-A1 | OXOLUPENE DERIVATIVES | VIIV Healthcare UK (No.5) Limited (GB) | 2017-09-20 | — | — | EP | disclosed |
| WO-2017134596-A1 | C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS | VIIV Healthcare UK (No.5) Limited (GB) | 2017-08-10 | — | — | WO | disclosed |
| EP-3129392-A1 | TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY, SUBSTITUTED IN POSITION 3 BY A NON-AROMATIC RING CARRYING A HALOALKYL SUBSTITUENT | VIIV Healthcare UK(No.4) Limited (GB) | 2017-02-15 | — | — | EP | disclosed |
| WO-2016077561-A1 | OXOLUPENE DERIVATIVES | BRISTOL-MYERS SQUIBB COMPANY (US) | 2016-05-19 | — | — | WO | disclosed |
| WO-2016077569-A1 | C17-ARYL SUBSTITUTED BETULINIC ACID ANALOGS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2016-05-19 | — | — | WO | disclosed |
| WO-2016077572-A1 | EXTENDED BETULINIC ACID ANALOGS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2016-05-19 | — | — | WO | disclosed |
| WO-2015195776-A1 | BETULINIC ACID DERIVATIVES WITH HIV MATURATION INHIBITORY ACTIVITY | BRISTOL-MYERS SQUIBB COMPANY (US) | 2015-12-23 | — | — | WO | disclosed |
| WO-2015157483-A1 | TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY, SUBSTITUTED IN POSITION 3 BY A NON-AROMATIC RING CARRYING A HALOALKYL SUBSTITUENT | BRISTOL-MYERS SQUIBB COMPANY (US) | 2015-10-15 | — | — | WO | disclosed |
| EP-2847208-A1 | C-17 BICYCLIC AMINES OF TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY | Bristol-Myers Squibb Company (US) | 2015-03-18 | — | — | EP | disclosed |
| EP-2814834-A1 | C-3 CYCLOALKENYL TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY | Bristol-Myers Squibb Company (US) | 2014-12-24 | — | — | EP | disclosed |
| WO-2014123889-A1 | C-19 MODIFIED TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY | BRISTOL-MYERS SQUIBB COMPANY (US) | 2014-08-14 | — | — | WO | disclosed |
| EP-2758419-A1 | NOVEL BETULINIC ACID DERIVATIVES WITH ANTIVIRAL ACTIVITY | Bristol-Myers Squibb Company (US) | 2014-07-30 | — | — | EP | disclosed |
| EP-2670765-A1 | C-17 AND C-3 MODIFIED TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY | Bristol-Myers Squibb Company (US) | 2013-12-11 | — | — | EP | disclosed |
| WO-2013169578-A1 | C-17 BICYCLIC AMINES OF TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-11-14 | — | — | WO | disclosed |
| WO-2013123019-A1 | C-3 CYCLOALKENYL TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-08-22 | — | — | WO | disclosed |
| WO-2013043778-A1 | NOVEL BETULINIC ACID DERIVATIVES WITH ANTIVIRAL ACTIVITY | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-03-28 | — | — | WO | disclosed |
| WO-2012106190-A1 | C-17 AND C-3 MODIFIED TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-08-09 | — | — | WO | disclosed |